UNSPSC 51144111: Benzphetamine

This classification denotes a cns stimulant and anorexiant with the molecular formula C17H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0M3S43XK27, chemically known as (r,s)-n-benzyl-alpha,n-dimethylphenethylamin but more generally known as benzfetamine, which bears US NIH Compound Identifier 2341. European Medicines Agency schedules Benzfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05748MIG.

UNSPSC 51144111 Benzphetamine is a Commodity code that does not align with state and local government procurement activity in the recent opportunities available. The three most recent solicitations tagged to this code—Seminole County's purchase of naloxone and drug deactivation systems, Texas Health and Human Services Commission's request for information on direct-to-manufacturer prescriptions, and Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products—address naloxone, prescription fulfillment, and generic pharmaceutical distribution respectively, none of which fall within the controlled-substance scope that benzphetamine nominally represents. The code shows little relevant recent activity for state and local procurement purposes.

The mismatch between the code's apparent subject matter and the actual work being solicited suggests either a tagging error in the underlying opportunity records or a fundamental divergence between UNSPSC's controlled-substance taxonomy and how state and local governments classify pharmaceutical procurement in practice. Business development professionals should verify the code classification independently before committing resources to pursue opportunities under this designation, as the recent opportunities provide no actionable intelligence about benzphetamine procurement patterns or buyer preferences.